Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 16;8(1):55-67.
doi: 10.1016/j.jacbts.2022.07.001. eCollection 2023 Jan.

Tie2-Cre-Induced Inactivation of Non-Nuclear Estrogen Receptor-α Signaling Abrogates Estrogen Protection Against Vascular Injury

Affiliations

Tie2-Cre-Induced Inactivation of Non-Nuclear Estrogen Receptor-α Signaling Abrogates Estrogen Protection Against Vascular Injury

Pang-Yen Liu et al. JACC Basic Transl Sci. .

Abstract

Using the Cre-loxP system, we generated the first mouse model in which estrogen receptor-α non-nuclear signaling was inactivated in endothelial cells. Estrogen protection against mechanical vascular injury was impaired in this model. This result indicates the pivotal role of endothelial estrogen receptor-α non-nuclear signaling in the vasculoprotective effects of estrogen.

Keywords: E2, 17β-estradiol; ECGM, endothelial cell growth medium; ER, estrogen receptor; ERαKI/KI, estrogen receptor-αknock-in/knock-in; LVEDD, left ventricular end-diastolic diameter; NOS, nitric oxide synthase; PI3K, phosphatidylinositol 3-kinase; PLA, proximity ligation assay; Vo2, oxygen consumption; cDNA, complementary deoxyribonucleic acid; eNOS, endothelial nitric oxide synthase; endothelial cells; estrogen receptor-α; non-nuclear signaling; tissue-specific regulation.

PubMed Disclaimer

Conflict of interest statement

This work was supported by the Japan Foundation for Applied Enzymology, Japan Heart Foundation Research Grant, SENSHIN Medical Research Foundation, Kobayashi Foundation (Dr Takimoto), Takeda Science Foundation (Drs Ueda and Takimoto), National Institutes of Health HL 052233, National Institutes of Health HL 136962, DK 062729 (Dr Liao), AHA Northeast Research Consortium Postdoctoral Fellowship, Uehara Research Fellowship (Dr Hiroi), and Tri-Service General Hospital Medical Research Foundation Grant TSGH-PH-E-111017 (Dr Liu). All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Mouse Model With Tie2-Cre-Induced Inactivation of ERα Non-Nuclear Signaling (A) A schematic diagram of gene targeting strategy. A single alteration was introduced into the mouse estrogen receptor-α (ERα) exon 4 by replacing Arg263 with alanine. (B) Wild-type ERα and mutated ERα expressions in isolated estrogen receptor-αknock-in/knock-in (ERαKI/KI)Tie2Cre endothelial cells with 17β-estradiol (E2) stimulation. (C) Nitric oxide synthase (NOS) activities in isolated ERαKI/KITie2Cre endothelial cells with E2 stimulation. (D) Hematoxylin-eosin (H&E) staining, proximity ligation assay (PLA) of p85α and ERα, and CD31 immunohistochemical staining in the carotid arteries treated with E2. Sections were counterstained with hematoxylin. Positive PLA signals are revealed by red dots; red arrow: positive PLA signals on endothelial cell area, black arrow: positive PLA signals on nonendothelial cell area. Scale bars = 20 μm. (E) Quantification results for PLA-positive cells. Data in B, C, and E were analyzed by the unpaired Student's t-test. ∗P < 0.05. Data are presented as mean ± SEM.
Figure 2
Figure 2
ERα Genomic Signaling Is Preserved in ERαKI/KITie2Cre+ Mice (A) Representative uterine morphologies of ERαKI/KITie2Cre mice after ovariectomy (OVX) and OVX+E2 supplementation. (B) ERαKI/KITie2Cre mice uterine weights (ERαKI/KITie2Cre−, n = 7-8; ERαKI/KITie2Cre+, n = 8). (C) Fertility analysis of ERαKI/KITie2Cre female mice. Litter sizes are shown as the number of pups per litter. (D) Endothelial estrogen response element–containing gene expressions by E2 stimulation. Data in B and D were analyzed by 2-way analysis of variance for “genotype × estrogen status” interaction. Data in C were analyzed by the unpaired Student's t-test. ∗P < 0.05. Data are presented as mean ± SEM. Abbreviations as in Figure 1.
Figure 3
Figure 3
Baseline Metabolic Characteristics and Serum E2 Concentration of ERαKI/KITie2Cre Mice (A) Oxygen consumption (VO2) normalized to body weight per hour for 24 hours. The graph demonstrates average VO2 during the light (day) and dark (night) phases. (B) Locomotor activity normalized to body weight per hour for 24 hours. The graph depicts average locomotor activity during the light (day) and dark (night) phases. The unpaired Student's t-test was performed separately in each phase. (C) Serum E2 concentrations in nonovariectomy ERαKI/KITie2Cre mice (ERαKI/KITie2Cre−, n = 5; ERαKI/KITie2Cre+, n = 9). Data are presented as mean ± SEM. Abbreviations as in Figure 1.
Figure 4
Figure 4
Assessments of Intimal Hyperplasia, Medial Thickening, and Fibrosis After Wire Injury (A) The protocol of the wire injury model. (B) Representative Elastica van Gieson (EVG) staining and (C) Masson’s trichrome (MT) staining images of carotid arteries 14 days after wire injury. Quantification results of (D) the intima-to-media ratio, (E) medial area (×103 μm2) (n = 4-8 for each group), and (F) fibrosis (area stained with blue green) in the medial layer (n = 5-13 in each group). Ptrend derived from comparison of the trends using 2-way analysis of variance for “genotype × estrogen status” interaction. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 in comparison between ERαKI/KITie2Cre− and ERαKI/KITie2Cre+ mice by Bonferroni’s post hoc correction for multiple comparisons. †P < 0.05 in comparison between E2+ and E2-; scale bar of upper panel = 64 μm, lower panel = 8 μm. Data are presented as mean ± SEM. E2+/- indicates with/without E2 pellet implantation. Abbreviations as in Figure 1.
Figure 5
Figure 5
Assessments of Re-Endothelialization in the Carotid Arteries 7 Days After Wire Injury (A) Representative images of Evans blue staining of carotid arteries. (B) Quantification results for the re-endothelialization area (%) determined by Evans blue staining (deendothelialized areas are stained with blue) (n = 4-6 in each group). (C) Representative images of CD31 immunohistochemical staining. (D) Quantification results for the endothelial coverage (% of luminal lining) (n = 5 in each group). Ptrend derived from comparison of the trends using 2-way analysis of variance for “genotype × estrogen status” interaction. ∗P < 0.05 in comparison between ERαKI/KITie2Cre− and ERαKI/KITie2Cre+ mice by Bonferroni’s post hoc correction for multiple comparisons. †P < 0.05 in comparison between E2+ and E2-; scale bar of upper panel = 1 mm, lower panel = 32 μm and 64 μm. Data are presented as mean ± SEM. E2+/- indicates with/without E2 pellet implantation. Abbreviations as in Figure 1.
Figure 6
Figure 6
Assessments of Inflammation in the Carotid Arteries 7 Days After Wire injury (A) Representative images of CD45 immunohistochemical staining. (B) Quantification results for the ratio of CD45 positive area/adventitial area (%) (n = 4-6 in each group); Ptrend derived from comparison of the trends using 2-way analysis of variance for “genotype × estrogen status” interaction. ∗P < 0.05 in comparison between ERαKI/KITie2Cre− and ERαKI/KITie2Cre+ mice by Bonferroni’s post hoc correction for multiple comparisons. †P < 0.05 in comparison between E2+ and E2-; scale bars = 100 μm and 200 μm. E2+/- indicates with/without E2 pellet implantation. Data are presented as mean ± SEM. Abbreviations as in Figure 1.

References

    1. Garcia M., Mulvagh S.L., Merz C.N., Buring J.E., Manson J.E. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118:1273–1293. - PMC - PubMed
    1. Grodstein F., Manson J.E., Colditz G.A., Willett W.C., Speizer F.E., Stampfer M.J. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med. 2000;133:933–941. - PubMed
    1. Atsma F., Bartelink M.L., Grobbee D.E., van der Schouw Y.T. Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause. 2006;13:265–279. - PubMed
    1. Stampfer M.J., Colditz G.A., Willett W.C., et al. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med. 1991;325:756–762. - PubMed
    1. Hodis H.N., Mack W.J., Henderson V.W., et al. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016;374:1221–1231. - PMC - PubMed

LinkOut - more resources